Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company held its 2022 Annual Meeting on
1. The election of the director nominee to serve as a Class II director for a three-year term to expire at the 2025 annual meeting of stockholders or until his successor is duly elected. The following Class II director was elected by the votes indicated.
For Withheld Broker Non-Votes A. Brooke Seawell 23,204,323 2,004,566 6,277,644
2. The ratification of the appointment of
For Against Abstain 30,759,064 514,798 212,671
3. The approval, on a non-binding, advisory basis, of the frequency of future advisory votes on the compensation of the Company's NEOs. "One year" was approved as the frequency of future advisory votes on NEO compensation by the votes indicated.
One Year Two Years Three Years Abstain Broker Non-Votes 24,136,540 176,725 614,875 280,749 6,277,644
4. The adoption of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock, at a ratio in the range of 1-for-5 to 1-for-50, such ratio to be determined by the Board of Directors and included in a public announcement. The amendment was adopted as the number of votes "FOR" represented a majority of the shares of our common stock outstanding as of the Record Date.
For Against Abstain 29,680,740 1,690,552 115,241
5. The adoption of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 300,000,000 to 450,000,000. The amendment was adopted as the number of votes "FOR" represented a majority of the shares of our common stock outstanding as of the Record Date.
For Against Abstain Broker Non-Votes 23,723,677 1,444,064 41,148 6,277,644
6. The approval, for purposes of complying with Nasdaq Listing Rule 5635, of the
issuance of shares of our common stock issuable upon conversion of the senior
secured convertible notes issued, or issuable, pursuant to the Note Purchase
Agreement, dated
For Against Abstain Broker Non-Votes 23,985,858 1,154,575 68,456 6,277,644
As previously reported in the Original Form 8-K, at the 2022 Annual Meeting, the Company conducted a non-binding advisory vote regarding the frequency of stockholder advisory approval of the compensation of the Company's NEOs. Among the options presented to stockholders (every "One Year," "Two Years" or "Three Years" or abstaining), the greatest number of votes were cast in favor of holding an advisory vote regarding the compensation of NEOs every year, which was also the frequency recommended to the stockholders by the Company's Board of Directors. After considering the results of the stockholder advisory vote, the Company -------------------------------------------------------------------------------- decided that it would hold an advisory vote on the compensation of the Company's NEOs every year, until the next required advisory vote on the frequency of such an advisory vote, which is expected to be held at the Company's 2028 Annual Meeting of Stockholders.
--------------------------------------------------------------------------------
© Edgar Online, source